Muscular Dystrophy is a terrible pediatric condition that has remained largely untreatable until recent medical developments. Listen to Finny Kuruvilla, CIO of Eventide Investments as he details some of the causes of the disorder as well as what one company is doing to attempt to not only slow down, but possibly cure, muscular dystrophy.
We partner with Eventide in the creation of our Biblically Responsible Investing portfolios, one of several options available to our clients. You can find this original video with some commentary (as well as other investing insights) at https://insights.eventideinvestments.com.
This communication is provided for informational purposes only and expresses views of Eventide Asset Management, LLC (“Eventide”), an investment adviser, and not necessarily those of Shepherd Wealth Partners, LLC. There is no guarantee that any investment strategy will achieve its objectives, generate profits, or avoid losses. Eventide’s values-based approach to investing may not produce desired results and could result in underperformance compared with other investments.